These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6104498)

  • 1. Cardiovascular effects of single oral doses of the new beta-adrenoceptor blocking agents betaxolol (SL 75212) in healthy volunteers.
    Cadigan PJ; London DR; Pentecost BL; Bianchetti G; Gomeni R; Kilborn JR; Morselli PL
    Br J Clin Pharmacol; 1980 Jun; 9(6):569-75. PubMed ID: 6104498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-adrenoceptor blocking effects and pharmacokinetics of betaxolol (SL 75212) in man.
    Giudicelli JF; Chauvin M; Thuillez C; Richer C; Bianchetti G; Gomeni R; Morselli PL
    Br J Clin Pharmacol; 1980 Jul; 10(1):41-9. PubMed ID: 6104973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of the new beta-adrenoceptor blocking agent betaxolol (SL 75212) in man after repeated oral administration.
    Bianchetti G; Blatrix C; Gomeni R; Kilborn JR; Larribaud J; Lücker PW; Thebault JJ; Trocherie S; Morselli PL
    Arzneimittelforschung; 1980; 30(11):1912-6. PubMed ID: 6109538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observation on the efficacy and pharmacokinetics of betaxolol (SL 75212), a cardioselective beta-adrenoceptor blocking drug.
    Balnave K; Neill JD; Russell CJ; Harron DW; Leahey WJ; Wilson R; Shanks RG
    Br J Clin Pharmacol; 1981 Feb; 11(2):171-80. PubMed ID: 6111331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood concentrations and pharmacodynamic effects of betaxolol (SL 75212) a new beta-adrenoceptor antagonist after oral and intravenous administration.
    Warrington SJ; Turner P; Kilborn JR; Bianchetti G; Morselli PL
    Br J Clin Pharmacol; 1980 Nov; 10(5):449-52. PubMed ID: 6108127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human pharmacokinetic and pharmacodynamic studies on Ro31-1118, a new beta-adrenoceptor antagonist.
    O'Connor PC; Arnold JM; Brown AN; Francis RJ; Finch MB; Galloway DB; Harron DW; McDevitt DG; Shanks RG
    Br J Clin Pharmacol; 1985 Mar; 19(3):319-27. PubMed ID: 2859047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The assessment in man of the beta-adrenoceptor blocking activity and cardioselectivity of H-I 42 BS, a long acting beta-adrenoceptor blocking drug.
    Pringle TH; Deering AH; Scott MG; Harron DW; Shanks RG
    Br J Clin Pharmacol; 1987 Apr; 23(4):411-23. PubMed ID: 2883988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic parameters of bevantolol in volunteers.
    Vermeij P; van Brummelen P
    Eur J Clin Pharmacol; 1986; 30(3):375-7. PubMed ID: 2874033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course of the bronchial response to salbutamol after placebo, betaxolol and propranolol.
    Palminteri R; Kaik G
    Eur J Clin Pharmacol; 1983; 24(6):741-5. PubMed ID: 6136412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of betaxolol, propranolol, and atenolol on isoproterenol-induced beta-adrenoceptor responses.
    Riddell JG; Shanks RG
    Clin Pharmacol Ther; 1985 Nov; 38(5):554-9. PubMed ID: 2865028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Betaxolol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension.
    Beresford R; Heel RC
    Drugs; 1986 Jan; 31(1):6-28. PubMed ID: 2866947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of betaxolol on heart rate at rest and during exercise.
    Kesteloot H; Missotten A; Coupez-Lopinot R; Sluyts R
    Acta Cardiol; 1982; 37(2):117-27. PubMed ID: 6125074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ro 31-1118, a new cardioselective beta-adrenoceptor antagonist. Pharmacokinetics and effects on heart rate and blood pressure in mild hypertensives.
    Jamieson M; Petrie JC; Webster J; Miller A; Harris RI; Francis RJ
    Eur J Clin Pharmacol; 1985; 29(4):395-9. PubMed ID: 2868899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of celiprolol, a new beta 1-alpha 2 blocker, on the cardiovascular response to exercise.
    Caruso FS; Berger BM; Darragh A; Weng T; Vukovich R
    J Clin Pharmacol; 1986 Jan; 26(1):32-8. PubMed ID: 2869057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison in healthy volunteers of the systemic beta adrenergic receptor blockade by beta blockader eye drops].
    de Dieuleveult C; Queinnec MC; Pinaud M; Souron R
    Ann Fr Anesth Reanim; 1989; 8(1):46-50. PubMed ID: 2565697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-adrenoceptor blocking effects and plasma levels of bornaprolol and propranolol in man.
    Thuillez C; Richer C; Duhazé P; Bergougnan L; Giudicelli JF
    Eur J Clin Pharmacol; 1985; 29(4):405-11. PubMed ID: 3912184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adimolol, a long acting beta-adrenoceptor blocker in man.
    Elliott HL; Jones CR; Deighton NM; Meredith PA; Reid JL
    Br J Clin Pharmacol; 1987 May; 23(5):511-21. PubMed ID: 2885022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
    Pringle TH; O'Connor PC; McNeill AJ; Finch MB; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1986 Mar; 21(3):249-58. PubMed ID: 2870732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of adimolol, labetalol and propranolol on heart rate and blood pressure in man.
    Riddell JG; Harron DW; Shanks RG
    Br J Clin Pharmacol; 1985 Apr; 19(4):405-10. PubMed ID: 2859871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics of dl- and l-moprolol in the human.
    Harvengt C; Desager JP
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):57-61. PubMed ID: 6120901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.